Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 156.25 | 63.10 | 82.00 | 76.75 | 1.0684 | 1.5280 |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 156.25 | 63.10 | 50.00 | 76.75 | 0.6515 | -0.5614 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 156.25 | 63.10 | 65.00 | 76.75 | 0.8469 | 0.1105 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 156.25 | 63.10 | 45.00 | 76.75 | 0.5863 | -0.6980 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 56.00 | 76.75 | 0.7296 | -0.3448 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 54.00 | 76.75 | 0.7036 | -0.4240 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 171.00 | 243.75 | 0.7015 | -0.1123 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 217.00 | 243.75 | 0.8903 | 0.5323 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 312.50 | 180.13 | 91.00 | 243.75 | 0.3733 | -0.7908 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 245.00 | 243.75 | 1.0051 | 1.0236 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 312.50 | 180.13 | 193.00 | 243.75 | 0.7918 | 0.1714 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 312.50 | 180.13 | 259.00 | 243.75 | 1.0626 | 1.2984 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 312.50 | 180.13 | 829.00 | 243.75 | 3.4010 | 32.0515 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 4 | 312.50 | 180.13 | 165.00 | 243.75 | 0.6769 | -0.1821 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 312.50 | 180.13 | 111.00 | 243.75 | 0.4554 | -0.6702 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 312.50 | 180.13 | 334.00 | 243.75 | 1.3703 | 3.1163 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 312.50 | 180.13 | 319.00 | 243.75 | 1.3087 | 2.7049 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 312.50 | 180.13 | 3206.00 | 243.75 | 13.1528 | 732.1829 |
| SK-BR-3 | Nilotinib | 1 | uM | 4 | 312.50 | 180.13 | 286.00 | 243.75 | 1.1733 | 1.8847 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 335.00 | 243.75 | 1.3744 | 3.1446 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 312.50 | 180.13 | 159.00 | 243.75 | 0.6523 | -0.2486 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 312.50 | 180.13 | 243.00 | 243.75 | 0.9969 | 0.9859 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 312.50 | 180.13 | 270.00 | 243.75 | 1.1077 | 1.5282 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 312.50 | 180.13 | 125.00 | 243.75 | 0.5128 | -0.5671 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 312.50 | 180.13 | 252.00 | 243.75 | 1.0338 | 1.1585 |